| Cassidy Gail Mcgree, MS, CCC-SLP | |
|
3160 N Arizona Ave Ste 105, Chandler, AZ 85225-7122 | |
| (480) 390-0483 | |
| Not Available |
| Full Name | Cassidy Gail Mcgree |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3160 N Arizona Ave Ste 105, Chandler, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447890389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| 235Z00000X | Speech-language Pathologist | TSLP12201 (Arizona) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Cassidy Gail Mcgree, MS, CCC-SLP 1480 E Pecos Rd Apt 2085, Gilbert, AZ 85295-1841 Ph: (406) 533-9806 | Cassidy Gail Mcgree, MS, CCC-SLP 3160 N Arizona Ave Ste 105, Chandler, AZ 85225-7122 Ph: (480) 390-0483 |
News Archive
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, has initiated SANET-ep, a Phase III sulfatinib (HMPL-012) registration trial in China in patients with extra-pancreatic neuroendocrine tumors ("NETs"), which are all non-pancreatic NETs, including, for example, NETs originating in the lymph, lung and across the gastrointestinal tract.
Senesco Technologies, Inc. reported today that it was informed on July 26th that the U.S. Food and Drug Administration has granted orphan-drug designation for the company's lead drug candidate SNS01-T for treatment of both mantle cell lymphoma and diffuse large B-cell lymphoma.
A team of researchers led by Vicente Gilsanz, MD, PhD, director of Clinical Imaging at The Saban Research Institute of Children's Hospital Los Angeles, determined that the onset of puberty was the primary influence on adult bone mineral density, or bone strength. Length of puberty did not affect bone density.
ReVision Optics, a leading company in the research, development and manufacture of custom optical products to correct and maintain vision, announced today that it has begun its US clinical trial of the PresbyLens® corneal inlay. The clinical trial will evaluate the PresbyLens® corneal inlay for the correction of presbyopia, the age-related loss of near vision. The study began on April 6th with the treatment of three subjects by clinical investigator Dr. Stephen Slade of the Slade & Baker Vision Center in Houston, Texas.
PolyTherics Ltd, a biopharmaceutical company specialised in the targeted application of polymers to biopharmaceuticals, and Alligator Bioscience AB ("Alligator"), a biotechnology company applying proprietary technology to the improvement of proteins, today announced the establishment of a new alliance.
› Verified 9 days ago
Ms. Heather Marie Liu, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6543 S Teresa Dr, Chandler, AZ 85249 Phone: 480-329-7600 | |
Allison Dawn Smith, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 815 E Warner Rd, Suite 106, Chandler, AZ 85225 Phone: 480-963-5800 Fax: 480-963-5805 | |
Miss Demaurice Jiana Basile, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Alicia Rowlett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3400 N Alma School Rd Apt 2034, Chandler, AZ 85224 Phone: 719-671-7172 | |
Gail Cisneros, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Gabrielle Christine Goldsmith, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 964 E Cherry Hills Dr, Chandler, AZ 85249 Phone: 509-217-3367 | |
Lauren Mead, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3160 N Arizona Ave Ste 105, Chandler, AZ 85225 Phone: 480-365-9981 |